Contratos
Contract
Phase 1 study of DNX-2401 for recurrent malignant brain tumo
edit_calendar
Duration: from 15 July 2022 to 15 November 2025
(40 months)
Current
euro
0.00 EUR
Of International (non-EU) scope.
Researchers
Marta María
Alonso Roldán
Leader